(TUSK) Mammoth Energy - Ratings and Ratios

Mammoth Energy Services, Inc. (NASDAQ:TUSK) is a diversified energy services company operating across the United States, Canada, and select international markets. The company is organized into four core business segments: Well Completion Services, Infrastructure Services, Natural Sand Proppant Services, and Drilling Services. Its service portfolio includes pressure pumping, hydraulic fracturing, sand hauling, and water transfer solutions, supported by master service agreements. The company also provides comprehensive infrastructure solutions, including engineering, design, construction, and maintenance of high-voltage transmission lines, substations, and distribution systems, as well as storm repair and restoration services. Additionally, Mammoth Energy Services engages in the mining, processing, and sale of natural sand proppant, complemented by logistics services for frac sand delivery. The company further offers contract land and directional drilling services, rig moving, aviation support, equipment rental, remote accommodations, and equipment manufacturing. Its customer base spans government-funded utilities, private and public investor-owned utilities, independent oil and natural gas producers, and land-based drilling contractors. Mammoth Energy Services, Inc. was founded in 2014 and is headquartered in Oklahoma City, Oklahoma. The company was previously known as Mammoth Energy Partners LP before changing its name in October 2016.

Based on the provided and , the 3-month forecast for Mammoth Energy Services, Inc. (NASDAQ:TUSK) suggests a challenging outlook. The stock is trading below its 20-, 50-, and 200-day moving averages (SMA 20: 2.71, SMA 50: 2.90, SMA 200: 3.49), indicating bearish momentum. The average trading volume (20d: 78,538) remains modest, with a low ATR (0.16), reflecting reduced price volatility. From a fundamental perspective, the companys negative return on equity (RoE: -73.62) and lack of profitability (P/E: 0.00) raise concerns about its financial health. However, the low price-to-book (P/B: 0.41) and price-to-sales (P/S: 0.59) ratios suggest potential undervaluation. Over the next three months, the stock may face downward pressure due to weak technical indicators and earnings challenges, but its low valuations could attract value investors seeking turnaround opportunities.